Preliminary study finds GLP-1 drugs (semaglutide, etc.) are associated with 10% fewer emergency visits and lower medication use for chronic migraine patients.

Each monthly installment examines an aspect of Alzheimer's disease care, including making and delivering the diagnosis; ...

Citing rising costs and shortfalls in federal support, about 20 states are toughening eligibility requirements for patients in drug assistance programs.

Between four and 10 million people in the U.S. have fibromyalgia. Many doctors look askance at the disorder, leading some patients to seek pain relief from substance use.

The warning label placed on all estrogen-based treatments since 2003 was based on an outdated and flawed government-funded study.

Many cities are considering involuntary substance use treatment as a solution to drug use among the homeless. But research doesn’t support this strategy.

Chronic migraine sufferers taking GLP-1 drugs were about 10% less likely to need ER care for a migraine attack compared to those taking a standard first-line migraine drug, researchers are scheduled ...

Families in Kensington and beyond are grappling with a crisis shaped by migration, disinvestment, and a public health response that many say has failed them.

The COVID-19 pandemic caused a spike in the number of people turning to medication to help relieve anxiety but top health ...

On the FDA’s docket this month are two decisions pushed back from 2025, including one for a rare form of obesity and another for dry eye disease.

When people struggle with anxiety and depression, the most effective approach is often to combine medication and ...

Ten years after a declaration of a state of emergency around the toxic drug crisis, it continues to kill more people every month than died in an entire year when heroin dominated the market.